Alessandra Maleddu

Medical Oncologist/ Sarcoma/ Early diagnosis /Digital Health

[Agenus @Agenus_Bio]

Dr. Breelyn Wilky will present data on botensilimab, a novel innate/adaptive immune activator, +/-botensilimab in cold and IO refractory solid tumors at #TheRoadTaken. Make sure to register for the webcast! In person attendance is at capacity. Sign-up at: https://t.co/kXnVxGBve8

[Breelyn Wilky, MD, FASCO 🎗 @breelynwilkyMD]

Awesome local tumor management section of @NationalLMSF #researchroundtable22, surgical considerations, XRT, precision medicine…

[Palma Dileo @dileo_palma]

Save the Date! CTOS Webinar on Desmoid Fibromatosis October 20th
Excited to announce the 1st CTOS Webinar that will kick off a series of webinars hosted by CTOS to promote disease-specific educational content.
The webinar will focus on Desmoid, the 2022 Sarcoma of the Year.

[Alessandro Gronchi @alegronchi]

Bernd Kasper and ⁦@jeanyvesblay⁩ at ⁦@myESMO⁩ just before the Presidential Symposium I, where the amazing results of the DeFi study of nirogacestat in #desmoid will be presented. JY very relaxed and Bernd a bit stressed out! Don’t worry Bernd! You’ll do great! ⁦

[Alessandra Maleddu @AMaleddu]

Absolutely delighted to join a fantastic team at @CUCancerCenter! Thank you @breelynwilkyMD for this exciting opportunity and @dileo_palma for being such a great mentor!

[Breelyn Wilky, MD, FASCO 🎗 @breelynwilkyMD]

Overjoyed to finally announce the imminent arrival 7/1/22 of our new #sarcoma faculty at @CUCancerCenter - Dr. Alessandra Maleddu, @amaleddu previously at University College London Hospitals with @dileo_palma et al! #countingthedays Welcome to Colorado, and back to Twitter!